We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

Informazioni su ADA Walking Challenge 77th SS

Supporta la 77 ° Sessione Scientifica Walking sfida in corso a San Diego

App supporting the American Diabetes Association's third annual Walking Challenge, supported by AstraZeneca. The Walking Challenge will be held during the ADA's 77th Scientific Sessions held June 9 - 13, 2017 in San Diego, CA.

The Challenge will encourage Session attendees to “walk the walk” and engage in some friendly competition. The ADA will be providing ADA-branded Bluetooth connected Activity Trackers to the first 1,200 Walking Challenge participants. These trackers will track the number of steps you take during Sessions and then wirelessly send that data to a custom ADA Challenge app on your iOS device. The top 25 individual steppers and total number of cumulative participant steps will be displayed on plasmas screens at select convention site locations including AstraZeneca’s exhibitor booth (#1135).

The ADA challenges all attendees, and those participating in the challenge to take 77,000 steps over the days of the event to commemorate our 77 years of service to those affected by diabetes.

Novità nell'ultima versione 3.1

Last updated on Jun 27, 2017

Supports ADA 77th Scientific Sessions

Traduzione in caricamento...

Informazioni APP aggiuntive

Ultima versione

Richiedi aggiornamento ADA Walking Challenge 77th SS 3.1

Caricata da

علي موسى

È necessario Android

Android 4.4+

Mostra Altro

ADA Walking Challenge 77th SS Screenshot

Lingua
Iscriviti ad APKPure
Sii il primo ad accedere alla versione anticipata, alle notizie e alle guide dei migliori giochi e app Android.
No grazie
Iscrizione
Abbonato con successo!
Ora sei iscritto ad APKPure.
Iscriviti ad APKPure
Sii il primo ad accedere alla versione anticipata, alle notizie e alle guide dei migliori giochi e app Android.
No grazie
Iscrizione
Successo!
Ora sei iscritto alla nostra newsletter.